WO2025109372 - COMPOSITION AND METHOD FOR REDUCING RISK OF HYPOCALCEMIA IN PERIPARTURIENT RUMINANT ANIMALS
National phase entry is expected:
Publication Number
WO/2025/109372
Publication Date
30.05.2025
International Application No.
PCT/IB2024/000663
International Filing Date
20.11.2024
Title **
[English]
COMPOSITION AND METHOD FOR REDUCING RISK OF HYPOCALCEMIA IN PERIPARTURIENT RUMINANT ANIMALS
[French]
COMPOSITION ET PROCÉDÉ POUR RÉDUIRE LE RISQUE D'HYPOCALCÉMIE CHEZ DES ANIMAUX RUMINANTS PÉRI-PARTURIENTS
Applicants **
PROTEKTA INC.
Inventors
JAKOBSEN, Morten
JAKOBSEN, Lasse
MARTIN, Rod
CONNELLY, Meghan
HOFFMAN, Patrick
Priority Data
18/830,440
10.09.2024
US
18/618,702
27.03.2024
US
63/601,401
21.11.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CIPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2527 | |
| EPO | Filing, Examination, Granting | 17275 | |
| Japan | Filing, Examination, Granting | 2514 | |
| South Korea | Filing, Examination, Granting | 2908 | |
| USA | Filing, Examination, Granting | 6540 |
Total:
31,764
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
A first method of reducing risk of periparturient hypocalcemia in a periparturient ruminant animal involves: measuring blood phosphorus concentration in the animal; and, administering a composition containing a phosphorus-binding compound and optionally, a pharmacologically acceptable carrier to the animal during at least part of a prepartum period of the animal. A second method of reducing risk of periparturient hypocalcemia in a periparturient ruminant animal involves: measuring an aluminum concentration in a feed composition; and, administering a composition containing a phosphorus-binding compound and optionally, a pharmacologically acceptable carrier to the animal during at least part of a prepartum period of the animal. In both methods, the composition having an effective amount of the phosphorus-binding compound to control the blood phosphorus concentration in a range of 1.5-3.5 mg P per dL of blood in the animal.[French]
Un premier procédé de réduction du risque d'hypocalcémie péri-parturiente chez un animal ruminant péri-parturient consiste à : mesurer la concentration de phosphore sanguin chez l'animal ; et, administrer une composition contenant un composé de liaison au phosphore et éventuellement, un support pharmacologiquement acceptable à l'animal pendant au moins une partie d'une période pré-partum de l'animal. Un second procédé de réduction du risque d'hypocalcémie péri-parturiente chez un animal ruminant péri-parturient consiste à : mesurer une concentration d'aluminium dans une composition d'alimentation ; et, administrer une composition contenant un composé de liaison au phosphore et éventuellement, un support pharmacologiquement acceptable à l'animal pendant au moins une partie d'une période pré-partum de l'animal. Dans les deux procédés, la composition présente une quantité efficace du composé de liaison au phosphore afin de réguler la concentration en phosphore sanguin dans une plage de 1,5 à 3,5 mg P par dL de sang chez l'animal.